21 Aug

Despite excitement, some worry CVS-Aetna merger could: “severely limit patient choice when it comes to seeing a doc… https://t.co/vKj6GOPjh1

16 Aug

FDA approves first-ever RNAi therapy – this one from @Alnylam for hATTR amyloidosis – this move could open another… https://t.co/dY6lbr14pr

14 Aug

Inside Edge is proud to support the Assoc. of Black Cardiologists in developing resource kits to make prior authori… https://t.co/Rb5uFmVCSi

Follow us